Home » Topics » Science » New compound

New compound
RSS

PDGFr tyrosine kinase inhibitor with potential in atherosclerosis

Aug. 25, 1997

Microtubule inhibitor with low toxicity and unique profile of CaM activity

Aug. 25, 1997

Indomethacin prodrug with potent antiinflammatory effects, low ulcerogenicity

Aug. 25, 1997

New COX-2 inhibitor series reported by Searle

Aug. 22, 1997

Nonpeptide CRF1 antagonist reduces cerebral infarction in rats

Aug. 21, 1997

Antimigraine agent in pharmacokinetic testing at HMR

Aug. 20, 1997

Merck KGaA begins development of cardioprotectant

Aug. 20, 1997

Imidazoline derivative displays potent antidiabetic effects in rats

Aug. 20, 1997

Digestive tract marker evaluated in diabetic patients with gastroenteropathies

Aug. 20, 1997

DPP-IV inhibition in the treatment of diabetes

Aug. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...